Literature DB >> 12690295

Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes.

Masataka Suzuki1, Masashige Shinkai, Hiroyuki Honda, Takeshi Kobayashi.   

Abstract

The hyperthermic effect of magnetic particles was examined in an in vivo study of mouse B16 melanoma. Magnetite cationic liposomes (MCLs) have a positive surface charge and generate heat under an alternating magnetic field (AMF) by hysteresis loss. MCLs were injected into melanoma nodules, which were then subjected to an AMF. The mice were divided into four groups: group I (control), group II (hyperthermia at 43 degrees C for 30 min, once), group III (hyperthermia at 46 degrees C for 30 min, once) and group IV (hyperthermia at 46 degrees C for 30 min, twice). Complete tumour regression was observed in 90% of the mice in group IV, while no mice in groups I and II and only 40% in group III showed regression. To examine whether hyperthermia caused immune induction in B16 melanoma, in vitro cytotoxicity assays and rechallenge experiments were performed. Cytotoxic activity was observed in the spleen cells of the cured mice in group IV. In the rechallenge experiment, 66% of the cured mice rejected melanoma cells. These results suggest that hyperthermia using MCLs is an effective therapy for melanoma, since this treatment can kill the tumour cells not only by heat but also by inducing an immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690295     DOI: 10.1097/00008390-200304000-00004

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  18 in total

Review 1.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

Review 2.  Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.

Authors:  Challa S S R Kumar; Faruq Mohammad
Journal:  Adv Drug Deliv Rev       Date:  2011-04-05       Impact factor: 15.470

3.  An in vitro and in vivo investigation of the biological behavior of a ferrimagnetic cement for highly focalized thermotherapy.

Authors:  Ana Portela; Mário Vasconcelos; Rogério Branco; Fátima Gartner; Miguel Faria; José Cavalheiro
Journal:  J Mater Sci Mater Med       Date:  2010-06-15       Impact factor: 3.896

4.  Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors.

Authors:  Seiko Toraya-Brown; Mee Rie Sheen; Peisheng Zhang; Lei Chen; Jason R Baird; Eugene Demidenko; Mary Jo Turk; P Jack Hoopes; Jose R Conejo-Garcia; Steven Fiering
Journal:  Nanomedicine       Date:  2014-02-22       Impact factor: 5.307

Review 5.  Magnetic nanoparticles and nanocomposites for remote controlled therapies.

Authors:  Anastasia K Hauser; Robert J Wydra; Nathanael A Stocke; Kimberly W Anderson; J Zach Hilt
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

6.  Multifunctional particles for melanoma-targeted drug delivery.

Authors:  Aniket S Wadajkar; Zarna Bhavsar; Cheng-Yu Ko; Bhanuprasanth Koppolu; Weina Cui; Liping Tang; Kytai T Nguyen
Journal:  Acta Biomater       Date:  2012-05-03       Impact factor: 8.947

7.  Acute and long-term effects of hyperthermia in B16-F10 melanoma cells.

Authors:  Mónica Pereira Garcia; José Roberto Tinoco Cavalheiro; Maria Helena Fernandes
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

8.  Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Authors:  Kowichi Jimbow; Yasue Ishii-Osai; Shosuke Ito; Yasuaki Tamura; Akira Ito; Akihiro Yoneta; Takafumi Kamiya; Toshiharu Yamashita; Hiroyuki Honda; Kazumasa Wakamatsu; Katsutoshi Murase; Satoshi Nohara; Eiichi Nakayama; Takeo Hasegawa; Itsuo Yamamoto; Takeshi Kobayashi
Journal:  J Skin Cancer       Date:  2013-02-21

9.  Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.

Authors:  Tomoaki Takada; Toshiharu Yamashita; Makito Sato; Akiko Sato; Ichiro Ono; Yasuaki Tamura; Noriyuki Sato; Atsushi Miyamoto; Akira Ito; Hiroyuki Honda; Kazumasa Wakamatsu; Shosuke Ito; Kowichi Jimbow
Journal:  J Biomed Biotechnol       Date:  2009-10-08

10.  Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles.

Authors:  Antonio Cervadoro; Chiara Giverso; Rohit Pande; Subhasis Sarangi; Luigi Preziosi; Jarek Wosik; Audrius Brazdeikis; Paolo Decuzzi
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.